Nitrofurantoin Olikla

Nitrofurantoin, the active ingredient in Nitrofurantoin Olikla, is a nitrofuran antibiotic presented as an oral tablet for oral use. It treats uncomplicated urinary tract infections in adult patients. GNH USA supplies Nitrofurantoin Olikla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrofurantoin is used to manage infections of the urinary tract caused by susceptible bacteria. - Uncomplicated urinary tract infection: eradicates the causative uropathogen and relieves urinary symptoms. - Acute cystitis: provides bacteriostatic or bactericidal activity to clear bladder infection. - Prophylaxis of recurrent urinary tract infection: reduces the frequency of future episodes when taken as a preventive regimen.

Nitrofurantoin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Loss of appetite: reduced desire to eat. - Headache: transient cranial discomfort. - Diarrhoea: loose stools occurring during therapy.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial lung disease presenting with cough and dyspnoea. - Hepatic injury: elevated liver enzymes or jaundice. - Peripheral neuropathy: tingling or numbness in extremities. - Hemolytic anaemia: especially in patients with G6PD deficiency. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - Blood dyscrasias: agranulocytosis or leukopenia.

Before prescribing Nitrofurantoin, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Renal function assessment: avoid use when creatinine clearance is below 60 mL/min. - G6PD deficiency: use with caution due to risk of haemolysis. - Pulmonary monitoring: discontinue if signs of lung toxicity develop. - Pregnancy and lactation: consider alternative agents unless benefits outweigh risks. - Drug‑induced liver injury: monitor liver function tests during prolonged therapy. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nitrofurantoin can interact with several medicines, altering its absorption or increasing toxicity.

Major Interactions (Avoid): - Antacids containing magnesium or aluminium: reduce oral absorption of nitrofurantoin. - Probenecid: increases plasma concentrations, raising risk of toxicity. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Methenamine: concurrent use can diminish antimicrobial efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: may increase nitrofurantoin serum levels, necessitating renal monitoring. - NSAIDs: combined renal stress may impair kidney function. - Oral contraceptives: possible reduction in contraceptive effectiveness, advise additional protection.